Post-approval studies (Phase 4)Study completedNCT05011669
What this trial is testing
The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia
Who this might be right for
Schizophrenia
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 200